A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome | Critical Care | 2017 | 397 |
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer | New England Journal of Medicine | 2019 | 391 |
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study | Lancet Oncology, The | 2019 | 270 |
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa | Clinical Infectious Diseases | 2019 | 245 |
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty | New England Journal of Medicine | 2018 | 189 |
A Systematic Review of Cognitive Behavioral Therapy and Behavioral Activation Apps for Depression | PLoS ONE | 2016 | 183 |
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa | Clinical Infectious Diseases | 2019 | 165 |
Mental health literacy measures evaluating knowledge, attitudes and help-seeking: a scoping review | BMC Psychiatry | 2015 | 145 |
Changes in colorectal cancer incidence in seven high-income countries: a population-based study | The Lancet Gastroenterology and Hepatology | 2019 | 132 |
Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action | European Journal of Internal Medicine | 2017 | 129 |
Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the Rush Memory and Aging Project | Lancet Neurology, The | 2019 | 129 |
The impact of vaccination on COVID-19 outbreaks in the United States | Clinical Infectious Diseases | 2021 | 109 |
What do we know about frailty in the acute care setting? A scoping review | BMC Geriatrics | 2018 | 104 |
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study | Lancet Infectious Diseases, The | 2016 | 103 |
Maternal immunisation: collaborating with mother nature | Lancet Infectious Diseases, The | 2017 | 92 |
Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States | JAMA Internal Medicine | 2018 | 89 |
Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis | Lancet Psychiatry,the | 2015 | 84 |
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People | Journal of Infectious Diseases | 2017 | 83 |
Projecting demand for critical care beds during COVID-19 outbreaks in Canada | Cmaj | 2020 | 83 |
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis | Lancet Infectious Diseases, The | 2019 | 82 |
Development and Validation of the Revised Patients' Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers | Drugs and Aging | 2016 | 81 |
A228 CAN SERRATED ADENOMA DETECTION RATE (SADR) BE USED TO EVALUATE THE PERFORMANCE OF CREDENTIALED SCREENING COLONOSCOPISTS IN THE NOVA SCOTIA COLON CANCER PREVENTION PROGRAM? | Journal of the Canadian Association of Gastroenterology | 2019 | 78 |
Influenza Vaccine Effectiveness Against Influenza-Associated Pneumonia and Pneumococcal Pneumonia in Older Adults: A Prospective Test-Negative Design Study | Open Forum Infectious Diseases | 2017 | 78 |
Impact of Antivirals in the Prevention of Serious Outcomes Associated with Influenza in Hospitalized Canadian Adults: A Pooled Analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN) | Open Forum Infectious Diseases | 2017 | 78 |
VALIDITY OF A SCALE TO MEASURE COMMITMENT TO HIP PROTECTORS AMONG CARE PROVIDERS IN LONG-TERM CARE | Innovation in Aging | 2017 | 78 |